论文部分内容阅读
目的观察思密达对小儿轮状病毒性肠炎的治疗疗效。方法将90例轮状病毒性肠炎患儿随机分为治疗组45例,对照组45例。两组均给予常规治疗,治疗组加用思密达口服。结果治疗组显效率为68.9%,对照组显效率为35.6%,两组显效率比较差异有统计学意义(P<0.01)。治疗组总有效率为91.1%,对照组总有效率为75.6%,两组总有效率比较差异有统计学意义(P<0.05)。结论思密达治疗轮状病毒性肠炎安全有效,值得临床应用。
Objective To observe the effect of Smecta on children with rotavirus enteritis. Methods Ninety children with rotavirus enteritis were randomly divided into treatment group (n = 45) and control group (n = 45). Both groups were given routine treatment, the treatment group with oral Smectite. Results The effective rate was 68.9% in the treatment group and 35.6% in the control group, with significant difference between the two groups (P <0.01). The total effective rate was 91.1% in the treatment group and 75.6% in the control group, and the total effective rate was significantly different between the two groups (P <0.05). Conclusion Smecta treatment of rotavirus enteritis is safe and effective, it is worth clinical application.